Keith Speights
TMFFishBiz
Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.
Recent Articles by Keith Speights

Jan 19, 2025
by Keith Speights
Which Vanguard ETFs Offer the Highest Dividend Yields?

Jan 19, 2025
by Keith Speights
3 Reasons Why I Won't Claim Social Security at Age 62

Jan 15, 2025
by Keith Speights
Is Moderna Stock a No-Brainer Buy on the Sell-Off?

Jan 13, 2025
by Keith Speights
Why Madrigal Pharmaceuticals Stock Is Sinking Today
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.